According to a recent study by Xue-Jun Zhao, MD, of Children’s Hospital of Pittsburgh in Pennsylvania, treatment with triheptanoin, also known as C7, could be effective in combating VLCAD deficiency.

Dr. Zhao’s lecture was presented as part of the International Network for Fatty Acid Oxidation Research and Management (INFORM) 2022 lecture series on May 23, 2022. Read the original article.